Rifaximin and Eluxadoline Utilization for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the United States and Budget Impact Analysis of Switching from Eluxadoline to Rifaximin
Abstract
Authors
LM Bloudek D Bozkaya K O'Hara SK Kirby S Shah